Programmed Cell Death News and Research

RSS
Pieris AG announces preclinical data for proprietary PRS-110 Anticalin compound

Pieris AG announces preclinical data for proprietary PRS-110 Anticalin compound

Mechanisms pathogenic viruses exploit to evade immune systems of hosts

Mechanisms pathogenic viruses exploit to evade immune systems of hosts

Multinational phase II study: GS-9450 can reduce markers of liver damage in patients with NASH

Multinational phase II study: GS-9450 can reduce markers of liver damage in patients with NASH

Stress hormones may suppress tumor growth: Study

Stress hormones may suppress tumor growth: Study

UCCS, Texas A&M Health Science Center announce collaboration in bioenergetics, immunology and cell life

UCCS, Texas A&M Health Science Center announce collaboration in bioenergetics, immunology and cell life

Gamma-tocotrienol kills prostate tumour cells in animal model studies

Gamma-tocotrienol kills prostate tumour cells in animal model studies

Pregnancy safe for breast cancer survivors, says study

Pregnancy safe for breast cancer survivors, says study

Insulin receptor vital for keeping neural stem cells alive

Insulin receptor vital for keeping neural stem cells alive

New findings promise to have fundamental significance in the fight against cancer

New findings promise to have fundamental significance in the fight against cancer

Discovery of novel cellular mechanism may help develop new treatments for cancer

Discovery of novel cellular mechanism may help develop new treatments for cancer

Severe inflammatory diseases: Blocking "death messenger" might be a promising treatment

Severe inflammatory diseases: Blocking "death messenger" might be a promising treatment

Synta Pharmaceuticals receives FDA approval for resuming elesclomol clinical development

Synta Pharmaceuticals receives FDA approval for resuming elesclomol clinical development

ATM tumor-suppressor also recognizes damage caused by ROS and orders autophagy

ATM tumor-suppressor also recognizes damage caused by ROS and orders autophagy

Roche Molecular Systems, Merck Sharp & Dohme announce cancer therapeutics collaboration

Roche Molecular Systems, Merck Sharp & Dohme announce cancer therapeutics collaboration

Researchers discover new strategy to overcome drug resistance in breast cancer

Researchers discover new strategy to overcome drug resistance in breast cancer

Researchers adopt new technique to inhibit cancer growth

Researchers adopt new technique to inhibit cancer growth

Stem cells intentionally cut and then repair their own DNA to develop new tissues

Stem cells intentionally cut and then repair their own DNA to develop new tissues

3SBio, Ascentage Pharma announce cancer therapeutics collaboration

3SBio, Ascentage Pharma announce cancer therapeutics collaboration

hESC and iPSC: Long-term stem cell evaluation and comparison study

hESC and iPSC: Long-term stem cell evaluation and comparison study

4SC AG announces the first treatment in Phase I clinical study of 4SC-205

4SC AG announces the first treatment in Phase I clinical study of 4SC-205

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.